Literature DB >> 21373986

Penile cancer: epidemiology and treatment.

Gustavo Cardoso Guimarães1, Rafael Malagoli Rocha, Stenio Cassio Zequi, Isabela Werneck Cunha, Fernando Augusto Soares.   

Abstract

Penile cancer is an aggressive disease, with major psychological and social impact. The etiological factors are poor genital hygiene, the presence of phimosis, viral infection, ultraviolet radiation, smoking, balanitis xerotic obliterans, and chronic lichen. Identifying prognostic factors is important to select patients at risk for lymph node metastasis and avoid unneeded lymphadenectomy. The presence of lymph node metastasis is currently the strongest prognostic factor but its evaluation is imperfect using clinical and laboratorial methods. The treatment for invasive penile cancer is based on the treatment of primary tumor, usually with amputation and regional lymphadenectomy, treatments that have a high morbidity rate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21373986     DOI: 10.1007/s11912-011-0163-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  56 in total

1.  Penile cancer in the UK: clinical presentation and outcome in 1998/99.

Authors:  Alastair W S Ritchie; Paul W Foster; Sarah Fowler
Journal:  BJU Int       Date:  2004-12       Impact factor: 5.588

2.  Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma.

Authors:  A Lopes; B M Rossi; F P Fonseca; S Morini
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

3.  Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival.

Authors:  Anne P Lont; Bin K Kroon; Simon Horenblas; Maarten P W Gallee; Johannes Berkhof; Chris J L M Meijer; Peter J F Snijders
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

4.  Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy.

Authors:  A Lopes; G S Hidalgo; L P Kowalski; H Torloni; B M Rossi; F P Fonseca
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

5.  Epidemiologic study on penile cancer in Brazil.

Authors:  Luciano A Favorito; Aguinaldo C Nardi; Mario Ronalsa; Stenio C Zequi; Francisco J B Sampaio; Sidney Glina
Journal:  Int Braz J Urol       Date:  2008 Sep-Oct       Impact factor: 1.541

Review 6.  [Value of targeted therapy for penile cancer].

Authors:  A Heidenreich; D Thüer; D Pfister
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role.

Authors:  Elsa F Velazquez; Antonio L Cubilla
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

9.  p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.

Authors:  Ademar Lopes; Artur Licio R Bezerra; Clovis Antonio Lopes Pinto; Sergio Vicente Serrano; Celso Abdon de MellO; Luisa Lina Villa
Journal:  J Urol       Date:  2002-07       Impact factor: 7.450

10.  Morbidity of modified prophylactic inguinal lymphadenectomy for squamous cell carcinoma of the penis.

Authors:  Timothy R Coblentz; Dan Theodorescu
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

View more
  11 in total

1.  Pathologic and imunohistochemical characterization of tumoral inflammatory cell infiltrate in invasive penile squamous cell carcinomas: Fox-P3 expression is an independent predictor of recurrence.

Authors:  José Vassallo; André Fellipe Freitas Rodrigues; Antonio Hugo J F M Campos; Rafael Malagoli Rocha; Isabela Werneck da Cunha; Stênio Cássio Zequi; Gustavo Cardoso Guimarães; Francisco Paulo da Fonseca; Ademar Lopes; Antonio Cubilla; Fernando Augusto Soares
Journal:  Tumour Biol       Date:  2015-01-05

2.  Tumor Location May Independently Predict Survival in Patients With M0 Squamous Cell Carcinoma of the Penis.

Authors:  Kai Li; Xiang Le; Jianqing Wang; Caibin Fan; Jian Sun
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

3.  Editorial Comment: Role of Diffusion-Weighted Mag-netic Resonance Imaging (DWMRI) in Assessment of Primary Penile Tumor Characteristics and Its Corre-lations With Inguinal Lymph Node Metastasis: A Prospective Study.

Authors:  Gustavo Cardoso Guimarães
Journal:  Int Braz J Urol       Date:  2020 Nov-Dec       Impact factor: 1.541

4.  SOD2 immunoexpression predicts lymph node metastasis in penile cancer.

Authors:  Lara Termini; José H Fregnani; Enrique Boccardo; Walter H da Costa; Adhemar Longatto-Filho; Maria A Andreoli; Maria C Costa; Ademar Lopes; Isabela W da Cunha; Fernando A Soares; Luisa L Villa; Gustavo C Guimarães
Journal:  BMC Clin Pathol       Date:  2015-03-03

5.  Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.

Authors:  Hellen Kuasne; Ilce Mara de Syllos Cólus; Ariane Fidelis Busso; Hector Hernandez-Vargas; Mateus Camargo Barros-Filho; Fabio Albuquerque Marchi; Cristovam Scapulatempo-Neto; Eliney Ferreira Faria; Ademar Lopes; Gustavo Cardoso Guimarães; Zdenko Herceg; Silvia Regina Rogatto
Journal:  Clin Epigenetics       Date:  2015-04-18       Impact factor: 6.551

6.  Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.

Authors:  Hellen Kuasne; Mateus C Barros-Filho; Ariane Busso-Lopes; Fábio A Marchi; Maisa Pinheiro; Juan J M Muñoz; Cristovam Scapulatempo-Neto; Eliney F Faria; Gustavo C Guimarães; Ademar Lopes; José C S Trindade-Filho; Maria Aparecida C Domingues; Sandra A Drigo; Silvia R Rogatto
Journal:  Oncotarget       Date:  2017-02-28

7.  Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.

Authors:  Fabio Albuquerque Marchi; David Correa Martins; Mateus Camargo Barros-Filho; Hellen Kuasne; Ariane Fidelis Busso Lopes; Helena Brentani; Jose Carlos Souza Trindade Filho; Gustavo Cardoso Guimarães; Eliney F Faria; Cristovam Scapulatempo-Neto; Ademar Lopes; Silvia Regina Rogatto
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

8.  Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.

Authors:  Anthony Adimonye; Elzbieta Stankiewicz; Sakunthala Kudahetti; Giorgia Trevisan; Brendan Tinwell; Cathy Corbishley; Yong-Jie Lu; Nick Watkin; Daniel Berney
Journal:  Oncotarget       Date:  2018-03-23

9.  Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis.

Authors:  Xiheng Hu; Jianghai Huang; Sailan Wen; Jun Fu; Minfeng Chen
Journal:  Oncotarget       Date:  2017-06-28

10.  PIK3CA copy number aberration and activation of the PI3K-AKT-mTOR pathway in varied disease states of penile cancer.

Authors:  Anthony Adimonye; Elzbieta Stankiewicz; Susannah La-Touche; Sakunthala Kudahetti; Giorgia Trevisan; Brendan Tinwell; Cathy Corbishley; Yong-Jie Lu; Nick Watkin; Daniel Berney
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.